These markers include Human Epidermal Growth Factor Receptor 2 (HER-2), estrogen receptors (ERs), and progesterone receptors (PRs), which serve as therapeutic targets for breast cancer drugs and indicators for selecting effective treatment strategies. The gene discussed is ERBB2; the disease is breast cancer.